Fair Comment Jovann.
My preface would have been for a 1:4 consolidation with projects locked in.
This way the sp on consolidation hopefully would be worth more than the twenty cents.
Presently the company is offering consolidation with so many decisions yet to be confirmed. I would have thought that NSL's venture into India would have the brokers all over it, but due to the limited research available, maybe are sitting on the sidelines waiting. The present market conditions certainly dont help from an investors view point, but if the project has so much potential, as we are constantly told by management, why then has the market not yet latched on.
Like I mentionned before, I would like to see the company update the market regularly till consolidation date.
Some investors have waited, like you, over three years to see NSL make good of its Indian Venture.
I would hope it does take another 3 years to get there.
That's it for now.
- Forums
- ASX - By Stock
- consolidation
Fair Comment Jovann.My preface would have been for a 1:4...
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ELE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.27M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
ELE (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online